Pneumococcal Vaccine

Aka: Pneumococcal Vaccine, Polyvalent pneumococcal Vaccine, Pneumovax 23, Pneumovax, Pnu-Imune 23

1. See Also
   1. Pneumococcal Conjugate Vaccine
2. Pharmacokinetics
   1. Purified capsular polysaccharide antigens from 23 serotypes
   2. These serotypes are responsible for 88% of invasive pneumococcal disease
3. Indications: Adult Vaccine
   1. Age 65 years and older
   2. Sickle Cell disease
   3. Functional or anatomic Asplenia
      1. Administer 2 weeks prior to splenectomy
   4. Nephrotic Syndrome or Chronic Renal Failure
   5. Immunosuppression
   6. Human Immunodeficiency Virus
   7. Heart, lung or liver disease
   8. Asthma
   9. Tobacco users (starting at age 50 years)
   10. High risk environments
       1. Native American Reservations
       2. Nursing Homes
4. Indications: Children (age 2 years and older)
   1. Chronic illness
   2. Functional Asplenia or anatomic Asplenia
   3. Immunocompromised state
   4. Renal disease (e.g. Nephrotic Syndrome, Renal Failure)
5. Dosing
   1. One dose is sufficient for most patients at age 65 years
   2. Indication for single dose ages 2 to 64 years
      1. See Indications above
      2. Give a second dose at age 65 or at least 5 years after the last dose
   3. Indication for 2 doses at more than 5 years apart at ages 2 to 64 years
      1. Give third dose at age 65 years or at least 5 years after the last dose
      2. Chronic renal disease (Renal Failure, Nephrotic Syndrome)
      3. Asplenia
      4. Sickle Cell Anemia
      5. Immunocompromised state
         1. HIV Infection
         2. Leukemia
         3. Lymphoma
         4. Multiple Myeloma
         5. Iatrogenic (e.g. organ transplant, Radiation Therapy, Chemotherapy)
6. Precautions
   1. Administer to high risk women before pregnancy
   2. ACIP recommends avoiding in pregnancy